Press Releases

Date Title
October 29, 2019 Progenity Presents Data at ACG 2019
Highlighting Opportunities for Technologies Aimed at Improving Diagnosis and Treatment of Gastrointestinal Disorders SAN DIEGO, October 29, 2019  – Progenity, Inc., a privately held biotechnology company, presented three posters this week at the 2019 American College of Gastroenterology Annual
October 22, 2019 Progenity Strengthens Executive Leadership Team with Appointment of Sami Shihabi as Chief Commercial Officer
SAN DIEGO, October 22, 2019  – Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, announced the promotion of Sami Shihabi to chief commercial officer.
September 18, 2019 Progenity Acquires Medimetrics Assets and Strengthens Global Leadership Position for Ingestible Device Technologies
This acquisition further strengthens Progenity’s existing intellectual property portfolio and development of ingestible devices designed to advance research, diagnosis, and treatment for conditions of the gastrointestinal (GI) tract. SAN DIEGO, September 18, 2019  – Progenity, Inc., a privately
August 7, 2019 Progenity Announces Appointment of Brian Kotzin, M.D., to its Board of Directors
Dr. Kotzin’s experience in the development of novel biotherapeutics, especially in autoimmune and inflammatory diseases, will provide valuable guidance as the company advances its pipeline of precision therapeutics/biotherapeutics and diagnostics. SAN DIEGO, August 7, 2019  – Progenity, Inc., a
June 25, 2019 NYU Winthrop and Progenity Collaborate to Develop Diagnostic Test to Assess Risk for Preterm Birth
Announcing a collaborative research and development initiative for women’s health with a focus on preterm births. Mineola, NY and San Diego, CA  – NYU Winthrop Hospital and Progenity, Inc., today announced a collaborative research and development initiative for women’s health with a focus on
June 11, 2019 Progenity to Present at Raymond James Life Sciences and MedTech Conference
Participating in New York, June 18 and 19. SAN DIEGO, June 11, 2019  – We will be participating in the Raymond James Life Sciences and MedTech Conference in New York, June 18 and 19. Chief Executive Officer Harry Stylli, Ph.D., will present a corporate overview on Wednesday, June 19, from 10:55 AM
June 5, 2019 Progenity Strengthens Executive Team with the Addition of Eric d’Esparbes as Chief Financial Officer
Announcing our new Senior Vice President and Chief Financial Officer (CFO). SAN DIEGO—June 5, 2019 —Progenity, Inc., a privately held biotechnology company, today announced the hire of Eric d’Esparbes as Senior Vice President and Chief Financial Officer (CFO). Mr.
May 22, 2019 Progenity Presents Proof-of-Concept Data on Proprietary Ingestible Technologies for Gastrointestinal Disorders
We announced results from three studies that represent potential breakthrough systems for diagnosing, treating, and monitoring digestive diseases through ingestible technologies. SAN DIEGO—May 22, 2019 —Progenity, Inc., a privately held biotechnology company developing proprietary precision
May 7, 2019 Progenity Featured in GenomeWeb
Highlighting the Resura® Prenatal Test Progenity was featured in  GenomeWeb  highlighting our newest cfDNA option, the Resura ®  Prenatal Test, which provides custom-designed testing for families with rare disease. See the  full article  in  GenomeWeb  for our recent developments in the noninvasive
May 6, 2019 Progenity to Showcase New Data at Digestive Disease Week®
Progenity, Inc., a privately held biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, this week announced three upcoming poster presentations. SAN DIEGO—May 6, 2019 –Progenity, Inc., a privately
Displaying 71 - 80 of 86